NCT06142838招募中不适用
Community Pharmacist Intervention to Enhance Adherence in Cardiovascular Drug Initiators
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 1,600
- 试验地点
- 1
- 主要终点
- NIH Patient Reported Outcomes Measurement Information System (PROMIS) Medication Adherence Scale (PMAS)
研究概览
简要总结
The goal of this clinical trial is to evaluate a community pharmacist intervention aimed at improving medication adherence in patients starting newly prescribed medication for cardiovascular disease prevention. The main questions it aims to answer are:
- Does this community pharmacist intervention improve medication adherence?
- Which patients benefit the most from the intervention?
- How do patients experience the start-up of newly prescribed medication (which questions do they have and do they experience side effects?)?
- How do patients and pharmacists experience the intervention?
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Double (Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients presenting with a first prescription for one of the following drug classes: antihypertensive drugs (= low-ceiling diuretics, beta blocking agents (excl. non-selective beta-blocking agents), ACE inhibitors, angiotensin II receptor blockers, calcium channel blockers), lipid-lowering drugs (= statins), antidiabetic drugs (= metformin, glucagon-like peptide-1 (GLP-1) analogues, sodium-glucose co-transporter 2 (SGLT2) inhibitors), or any combination thereof.
- •Age 18 years or older
- •Community-dwelling
排除标准
- •The drug is prescribed for a non-cardiovascular indication (e.g. beta-blocking agent for migraine prophylaxis)
- •Communication with the patient is not possible (e.g. due to cognitive impairment, insufficient knowledge of Dutch or French language)
结局指标
主要结局
NIH Patient Reported Outcomes Measurement Information System (PROMIS) Medication Adherence Scale (PMAS)
时间窗: At 6 weeks and at 12 weeks follow-up
Patient-reported measure of medication adherence
次要结局
- Healthcare utilization(Over 12 weeks post-baseline)
- Medication Possession Ratio (MPR)(Over 26 weeks post-baseline)
- Medication knowledge questionnaire(At 6 weeks and at 12 weeks follow-up)
- Treatment response(At baseline and at 12 weeks follow-up)
- Discontinuation rate(Over 26 weeks post-baseline)
- Beliefs about Medicines Questionnaire (BMQ-Specific)(At 6 weeks and at 12 weeks follow-up)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
A Community Pharmacist-led Intervention to Improve Adherence to Lipid-lowering TreatmentHypercholesterolemiaNCT00493337Utrecht Institute for Pharmaceutical Sciences373
Unknown
不适用
A Trial on the Role of Community Pharmacist in Improving Adherence and Clinical Outcomes in Post-InfarctionMyocardial Infarction, AcuteST Segment Elevation Myocardial InfarctionNon-ST Elevation Myocardial Infarction (nSTEMI)NCT03621111Azienda ULSS 5 Polesana120
已完成
不适用
Implementation of a Pharmacy-Intervention to Enhance Prescription and Use of Lipid-Lowering DrugsCardiovascular DiseasesNCT00509717Radboud University Medical Center70
已完成
不适用
Pharmacy Implementation Trial: Adherence to Antihypertensive TherapyHypertensionNCT00460343Radboud University Medical Center57
招募中
不适用
Leveraging Community Pharmacists to Optimize Smoking Cessation Services for Rural Smokers in AppalachiaSmoking CessationSmoking, CigaretteSmoking ReductionSmokingSmoking, TobaccoQuitting SmokingNCT05660525University of Virginia768